Ion-activated in situ gelling ophthalmic delivery systems of azithromycin

Indian Journal of Pharmaceutical Sciences

Volumn 73, Issue 6, 2011, Pages 615-620

  Vijaya, C ^a   Goud, K ^a  

^a Ultra College of Pharmacy   (India)

Author keywords

Azithromycin; in situ ocular gel; ion induced gelation; pectin

Indexed keywords

AZITHROMYCIN;

ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SAFETY; DRUG STABILITY; GELATION; GROWTH INHIBITION; NONHUMAN; RABBIT; STAPHYLOCOCCUS AUREUS; SUSTAINED DRUG RELEASE;

EID: 84866239886     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.100234     Document Type: Article

References (24)

1. Snyder RW, Glasser DB. Antibiotic therapy for ocular infection. W J Med 1994;161:579-84.
2. Huguet P, Bella L, Einterz E, Goldschmidt P, Bensaid P. Trachoma mass treatment with azithromycin 1.5% eye drops in Cameroon: Feasibility, tolerance and effectiveness. Br J Ophthalmol 2010;94:157-60.
3. Chisholm SA, Neal TJ, Alawattegama AB. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J Antimicrob Chemother 2009;64:353-8.
4. Dawson CR, Bowman LM. Topical treatment or prevention of ocular infections, United States Patent, US 6569443 B1, 2003.
5. Shen Y, Xu SJ, Wang SC, Tu JS. Determination of benzalkonium chloride in viscous ophthalmic drops of azithromycin by HPLC. J Zhejiang Univ Sci B 2009;10:877-82.
6. Abelson MB, Protzko EE, Shapiro AM. The AzaSite Clinical Study Group. A randomized trial assessing microbial eradication and clinical efficacy of 1% azithromycin ophthalmic solution vs tobramycin in adult subjects with bacterial conjunctivitis. Invest Ophthalmol Vis Sci 2006;47E-Abstract 3589.
7. Bourlais CL, Needham T, Leverge R. Ophthalmic drug delivery systems. Prog Retin Eye Res 1998;17:33-8.
8. Nanjawade BK, Manvi FV, Manjappa AS. In situ forming hydrogels for sustained ophthalmic drug delivery. J Control Release 2007;122: 119-34.
9. Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release 2001;73:205-11.
10. Qi H, Chen W, Wu C. Development of polaxamer analogs/Carbopol based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm 2007;337:178-87.
11. Carlfors J, Edsman K. Rheological evaluation of Gelrite in situ gels for ophthalmic use. Eur J Pharm Sci 1998;6:113-9.
12. Liu Z, Nie S, Pan W. Study of an alginate / HPMC based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm 2006;315:12-7.
13. Sindhu A, Bharath S, Basavaraj BV. Sustained ophthalmic delivery of ofloxacin from an ion activated in situ gelling system. Pakistan J Pharm Sci 2009;22:175-9.
14. Masteikova R, Chalupova Z. Stimuli sensitive hydrogels in controlled and sustained drug delivery. Medicina 2003;39:19-23.
15. Ni Y, Yates KM. In situ gel formation of pectin. United States Patent, US 6777000 B2, 2004.
16. Coviello T, Matricardi P, Marianecci C, Alhaique F. Polysaccharide hydrogels for modified release formulations. J Control Release 2009;119:5-24.
17. Indian Pharmacopoeia, Vol 2, Delhi: Government of India, Ministry of Health and Family Welfare;1996, p. 117-24.
18. Cappuccino JG, Sherman N. Microbiology-A Laboratory manual. 4th ed. Delhi: The Benjamin/Cummings Company; 1996, p. 272-3.
19. Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Therapeut 1944;82:377-90.
20. Sultana Y, Jain R, Rathod R, Asgar Ali, Aqil M. Advances in ophthalmic drug delivery systems-Part II. Pharmainfo.net. 2005, 3 (3). Available on http://www.pharmainfo.net/reviews/advances-ophthalmicdrug- delivery-systems- part-ii [Last cited on 8 Nov 2011].
21. Kumar S, Himmelstein KJ. Modification of in situ gelling behavior of carbopol solution by hydroxyl propyl methyl cellulose. J Pharm Sci 1995;84:344-8.
22. Allen LV Jr, Nicholas GP, Ansel HC. Pharmaceutical dosage forms and drug delivery systems. 8th ed. New Delhi: Wolters Kluwer; 2005, p. 546-50.
23. Colombo P, Santi P, Bettini R, Brazel CS, Peppas NA. Drug release from swelling controlled systems. In: Wise DL, ed. Handbook of Pharmaceutical Controlled release Technology. New York: Marcel Dekker; 2009, p. 187.
24. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 2005;57:1595-639.